310 related articles for article (PubMed ID: 24506618)
1. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
Zhang H; Zhong H; Barth RF; Cao M; Das IJ
Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
[TBL] [Abstract][Full Text] [Related]
2. Fractionated grid therapy in treating cervical cancers: conventional fractionation or hypofractionation?
Zhang H; Wang JZ; Mayr N; Kong X; Yuan J; Gupta N; Lo S; Grecula J; Montebello J; Martin D; Yuh W
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):280-8. PubMed ID: 17967516
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.
Zhang H; Donnelly ED; Strauss JB; Qi Y
Med Phys; 2016 Jan; 43(1):483. PubMed ID: 26745941
[TBL] [Abstract][Full Text] [Related]
4. Technical Note: Dosimetric impact of spherical applicator size in Intrabeam™ IORT for treating unicentric breast cancer lesions.
Saleh Y; Zhang H
Med Phys; 2017 Dec; 44(12):6706-6714. PubMed ID: 29072347
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric validation of the MCNPX Monte Carlo simulation for radiobiologic studies of megavoltage grid radiotherapy.
Zhang H; Johnson EL; Zwicker RD
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1576-83. PubMed ID: 17126214
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
7. A treatment planning approach to spatially fractionated megavoltage grid therapy for bulky lung cancer.
Costlow HN; Zhang H; Das IJ
Med Dosim; 2014; 39(3):218-26. PubMed ID: 24833301
[TBL] [Abstract][Full Text] [Related]
8. A simple dosimetric approach to spatially fractionated GRID radiation therapy using the multileaf collimator for treatment of breast cancers in the prone position.
Murphy NL; Philip R; Wozniak M; Lee BH; Donnelly ED; Zhang H
J Appl Clin Med Phys; 2020 Nov; 21(11):105-114. PubMed ID: 33119939
[TBL] [Abstract][Full Text] [Related]
9. Dose evaluation of Grid Therapy using a 6 MV flattening filter-free (FFF) photon beam: A Monte Carlo study.
Martínez-Rovira I; Puxeu-Vaqué J; Prezado Y
Med Phys; 2017 Oct; 44(10):5378-5383. PubMed ID: 28736809
[TBL] [Abstract][Full Text] [Related]
10. Is grid therapy useful for all tumors and every grid block design?
Gholami S; Nedaie HA; Longo F; Ay MR; Wright S; Meigooni AS
J Appl Clin Med Phys; 2016 Mar; 17(2):206-219. PubMed ID: 27074484
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic analysis of Intrabeam-based intraoperative radiation therapy in the treatment of unicentric breast cancer lesions utilizing a spherical target volume model.
Schwid M; Donnelly ED; Zhang H
J Appl Clin Med Phys; 2017 Sep; 18(5):184-194. PubMed ID: 28741896
[TBL] [Abstract][Full Text] [Related]
12. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).
Wang JZ; Li XA; D'Souza WD; Stewart RD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):543-52. PubMed ID: 12957268
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic benefits in grid irradiation on Tomotherapy for bulky, radiation-resistant tumors.
Narayanasamy G; Zhang X; Meigooni A; Paudel N; Morrill S; Maraboyina S; Peacock L; Penagaricano J
Acta Oncol; 2017 Aug; 56(8):1043-1047. PubMed ID: 28270018
[TBL] [Abstract][Full Text] [Related]
14. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
Balderson MJ; Kirkby C
Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
[TBL] [Abstract][Full Text] [Related]
15. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
Chan MKH; Chiang CL
Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
[TBL] [Abstract][Full Text] [Related]
19. A feasibility study: Selection of a personalized radiotherapy fractionation schedule using spatiotemporal optimization.
Kim M; Stewart RD; Phillips MH
Med Phys; 2015 Nov; 42(11):6671-8. PubMed ID: 26520757
[TBL] [Abstract][Full Text] [Related]
20. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
Song W; Battista J; Van Dyk J
Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
